{
    "organizations": [],
    "uuid": "871cf9d83d3fcf593bf13e89b4c2a753ee60f2f4",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/03/pr-newswire-fredrik-wetterlundh-joins-sobia-as-head-of-human-resources.html",
    "ord_in_thread": 0,
    "title": "Fredrik Wetterlundh Joins Sobi™ as Head of Human Resources",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "STOCKHOLM, April 3, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Fredrik Wetterlundh as Head of Human Resources. Fredrik will join Sobi on 9 April 2018 and be part of Sobi's Extended Leadership Team.\nFredrik Wetterlundh joins Sobi from Pfizer, where he held the position of Global Human Resources Lead in Pfizer's Global Supply organisation. He has extensive international experience in leading business-driven HR organisations, processes and projects in Asia, Europe, and North and Central America, and has supported a number of successful mergers and acquisitions and divestitures. Fredrik holds a degree in HR Management from the University of Lund, Sweden.\nGuido Oelkers, CEO and President of Sobi, sees the appointment as a valuable addition to the company. \"His experience from the pharmaceutical industry, numerous company integrations and the global roles he has held will be of great value for Sobi, supporting our organisation and our journey to become a global leader in rare diseases,\" he said.\nFredrik says he is excited to be joining Sobi. \"Sobi is a value-driven company with highly experienced employees and a strong culture. These are valuable assets to build on. I look forward to contributing to Sobi's growth strategy with my experience in implementing effective organisation and people strategies,\" he said.\nAbout Sobi™\nSobi™ is an international speciality healthcare company dedicated to rare diseases. Our vision is to be recognised as a global leader in providing access to innovative treatments that make a significant difference for individuals with rare diseases.\nThe product portfolio is primarily focused on treatments in Haemophilia and Specialty Care. Partnering in the development and commercialisation of products in specialty care is a key element of our strategy. Sobi has pioneered in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2017, Sobi had total revenues of SEK 6.5 billion and approximately 850 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com .\nFor more information please contact\nMedia relations\nLinda Holmström\nSenior Communications Manager\n+46-70-873-40-95\nlinda.holmstrom@sobi.com\nInvestor relations\nJörgen Winroth\nVice President\nHead of Investor Relations\n+1-347-224-0819\n+1-212-579-0506\njorgen.winroth@sobi.com\nThis information was brought to you by Cision http://news.cision.com\nhttp://news.cision.com/swedish-orphan-biovitrum-ab/r/fredrik-wetterlundh-joins-sobi--as-head-of-human-resources,c2486098\nThe following files are available for download:\nhttp://mb.cision.com/Main/14266/2486098/815016.pdf\nPDF\nhttp://news.cision.com/swedish-orphan-biovitrum-ab/i/fredrik-wetterlund2,c2379309\nFredrik Wetterlund2\nView original content: http://www.prnewswire.com/news-releases/fredrik-wetterlundh-joins-sobi-as-head-of-human-resources-300623209.html\nSOURCE Swedish Orphan Biovitrum AB",
    "published": "2018-04-03T12:30:00.000+03:00",
    "crawled": "2018-04-03T12:27:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "stockholm",
        "april",
        "swedish",
        "orphan",
        "biovitrum",
        "ab",
        "publ",
        "appointed",
        "fredrik",
        "wetterlundh",
        "head",
        "human",
        "resource",
        "fredrik",
        "join",
        "sobi",
        "april",
        "part",
        "sobi",
        "extended",
        "leadership",
        "team",
        "fredrik",
        "wetterlundh",
        "join",
        "sobi",
        "pfizer",
        "held",
        "position",
        "global",
        "human",
        "resource",
        "lead",
        "pfizer",
        "global",
        "supply",
        "organisation",
        "extensive",
        "international",
        "experience",
        "leading",
        "hr",
        "organisation",
        "process",
        "project",
        "asia",
        "europe",
        "north",
        "central",
        "america",
        "supported",
        "number",
        "successful",
        "merger",
        "acquisition",
        "divestiture",
        "fredrik",
        "hold",
        "degree",
        "hr",
        "management",
        "university",
        "lund",
        "sweden",
        "guido",
        "oelkers",
        "ceo",
        "president",
        "sobi",
        "see",
        "appointment",
        "valuable",
        "addition",
        "company",
        "experience",
        "pharmaceutical",
        "industry",
        "numerous",
        "company",
        "integration",
        "global",
        "role",
        "held",
        "great",
        "value",
        "sobi",
        "supporting",
        "organisation",
        "journey",
        "become",
        "global",
        "leader",
        "rare",
        "disease",
        "said",
        "fredrik",
        "say",
        "excited",
        "joining",
        "sobi",
        "sobi",
        "company",
        "highly",
        "experienced",
        "employee",
        "strong",
        "culture",
        "valuable",
        "asset",
        "build",
        "look",
        "forward",
        "contributing",
        "sobi",
        "growth",
        "strategy",
        "experience",
        "implementing",
        "effective",
        "organisation",
        "people",
        "strategy",
        "said",
        "international",
        "speciality",
        "healthcare",
        "company",
        "dedicated",
        "rare",
        "disease",
        "vision",
        "recognised",
        "global",
        "leader",
        "providing",
        "access",
        "innovative",
        "treatment",
        "make",
        "significant",
        "difference",
        "individual",
        "rare",
        "disease",
        "product",
        "portfolio",
        "primarily",
        "focused",
        "treatment",
        "haemophilia",
        "specialty",
        "care",
        "partnering",
        "development",
        "commercialisation",
        "product",
        "specialty",
        "care",
        "key",
        "element",
        "strategy",
        "sobi",
        "pioneered",
        "biotechnology",
        "capability",
        "protein",
        "biochemistry",
        "biologics",
        "manufacturing",
        "sobi",
        "total",
        "revenue",
        "sek",
        "billion",
        "approximately",
        "employee",
        "share",
        "sto",
        "sobi",
        "listed",
        "nasdaq",
        "stockholm",
        "information",
        "available",
        "information",
        "please",
        "contact",
        "medium",
        "relation",
        "linda",
        "holmström",
        "senior",
        "communication",
        "manager",
        "investor",
        "relation",
        "jörgen",
        "winroth",
        "vice",
        "president",
        "head",
        "investor",
        "relation",
        "information",
        "brought",
        "cision",
        "http",
        "http",
        "c2486098",
        "following",
        "file",
        "available",
        "download",
        "http",
        "pdf",
        "http",
        "c2379309",
        "fredrik",
        "wetterlund2",
        "view",
        "original",
        "content",
        "http",
        "source",
        "swedish",
        "orphan",
        "biovitrum",
        "ab"
    ]
}